Clinical Trial Update: Gleevec as Maintenance Therapy After Cytogenetic Response With Nilotinib in Newly Diagnosed Chronic Myelogenous Leukemia [NA]

View source ↗

Summary

Clinical trial update noting completion of a study evaluating Gleevec (imatinib) as maintenance therapy after cytogenetic response with nilotinib in newly diagn…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Myeloid Leukemia

Drugs mentioned

• Gleevec (Imatinib)
• Tasigna (nilotinib)

Snippet

Sponsor: American University of Beirut Medical Center | Conditions: Chronic Myelogenous Leukemia | NA | Status: COMPLETED